Abstract

Call for Abstracts

We invite you to present your work at the 12th International Congress of the Asia Pacific Society of Infection Control (APSIC 2026). Abstract submissions are welcome on a broad range of topics, including infection prevention and control (IPC), antimicrobial stewardship (AMS), antimicrobial resistance (AMR), and related themes (click here to see the abstract themes). Please select the most appropriate abstract theme to ensure accurate evaluation. The content of your abstract must align with the chosen theme.

Accepted abstracts will be published as an online supplement in Antimicrobial Stewardship and Healthcare Epidemiology (ASHE), the official journal of APSIC 2026, by Cambridge University Press.  For more information please click here 

Abstract Submission Guidelines

Please read this information carefully before preparing your abstract.

  • Abstract submissions must be made through the APSIC 2026 online submission portal. Abstracts sent via post, fax, or email WILL NOT BE ACCEPTED. 
  • The abstract must be written in English, including the title, author names, and affiliations.
  • Abstracts must represent original research, case studies, quality improvement projects or programmatic work related to the abstract themes [Click here to view the Abstract Themes].
  • Multiple submissions are allowed, but each abstract must be unique.
  • The abstract must follow the prescribed format and word count outlined during the online submission process.
  • The abstract must not be published or presented in any other scientific meeting at the time of submission.
  • The submitting author must ensure that all co-authors have reviewed the abstract, accepted the responsibility for its content, and agreed to be listed as co-authors. The submitting author is responsible for verifying the accuracy of all authors' names and affiliations at the time of submission. APSIC 2026 will not be held responsible for any errors in author details.
  • If the study involves human or animal subjects, the Methods section must include an ethics approval statement specifying the approving body and reference number. If ethics approval was not required, a justification must be provided.
  • Authors must thoroughly review and proofread their abstracts to ensure they are free of grammatical errors, as submissions will be published exactly as received. Linguistic accuracy is the responsibility of the authors, and no additional proofreading will be provided.
  • The submitting author must disclose any potential conflicts of interest for all authors during the abstract submission process to ensure that the content remains free from commercial influence or bias.
  • Authors can indicate their interest in applying for:
  • Abstracts must be submitted by 11:59 p.m. GMT+8, on 1 MARCH 2026. Late submissions will not be accepted.
  • Your abstract may be saved as a draft during the submission process. Once submitted, no changes can be made. A confirmation email will be sent upon successful submission. If you do not receive it,  please contact the APSIC 2026 Secretariat at info@apsic2026.my
  • Presenting authors must register as participants. Incomplete registration by 31 May 2026 will result in the abstract being withdrawn from the congress programme.

All abstracts must adhere to the following format:

  • A structured abstract format (please see below).
  • Word count: Maximum 300 words (including section sub-headings).
  • Title: Clear and concise, reflecting the main study focus.
  • Authors: Full names, affiliations, and email addresses.
  • Keywords: 3–5 relevant keywords.
  • Layout: NO tables/figures/references.
  • Abbreviations: Define them in parentheses at first mention.
  • Drug names: Only use generic (non-proprietary) names.
  • Commercial content: Promotional material is not permitted.

Original research abstracts format

  • Introduction and aim: Background, significance, and study objective.
  • Methods: Study design, population, data collection, and analysis.
  • Results: Key findings with relevant data/statistics.
  • Conclusion: Interpretation, implications, and recommendations.

Clinical case reports format

  • Introduction: Case context and objectives.
  • Case Presentation: Patient details, history, symptoms, and findings.
  • Intervention/Outcome: Management approach and results.
  • Discussion: Case significance and relevance.

check

Step 1
Register or Log In
Create an account or log in to the submission portal.
 

check

Step 2
Submit your abstract
Complete all fields required in the submission portal and click submit.
 

check

Step 3
Receive abstract
acknowledgement notification
You will receive a confirmation email after successful submission.
 

check

Step 4
Complete registration
The presenting author shall complete the registration process, including payment of the registration fee, by 31 May 2026.
 

The steps for abstract submission are as follows:

  • Step 1: Register or Log In
    Create an account or log in to the submission portal.
  • Step 2: Submit your abstract
    Complete all fields required in the submission portal and click submit.
  • Step 3: Receive abstract acknowledgement notification
    You will receive a confirmation email after successful submission.
  • Step 4: Complete registration
    The presenting author shall complete the registration process, including payment of the registration fee, by 31 May 2026.

  • Abstracts may be accepted as oral or poster presentations.
  • The presenting author must attend the congress in person.
  • Detailed presentation guidelines will be provided in the acceptance notification.
  • Accepted abstracts will be published in the APSIC 2026 e-abstract book and the online supplement of Antimicrobial Stewardship & Healthcare Epidemiology (ASHE), the official journal of APSIC 2026.
  • By submitting an abstract, authors agree to its publication on the APSIC 2026 website and in ASHE.
  • Authors presenting their work at APSIC 2026 grant permission for their presentations to be recorded, stored, and shared by the organisers.

For any inquiries regarding abstract submission, please contact the APSIC 2026 Secretariat at info@apsic2026.my. We look forward to receiving your submissions and to an engaging and productive congress in 2026.

Abstract Themes

Multidrug-resistant microorganisms prevention
Antimicrobial use
Antimicrobial stewardship (e.g. surveillance, programs, outpatient antibiotic therapy, beta-lactam delabelling, etc.)
Surveillance of multidrug-resistant microorganisms, antimicrobial use and healthcare-associated Infections: Disinfection and sterilization
Hand hygiene
Outbreak management in healthcare and community settings
Infection prevention and control strategies in healthcare setting
Infection prevention and control and antimicrobial stewardship in special population (e.g. intensive care unit, long-term care facilities and nursing homes, paediatric, immunocompromised host, etc.)
Infection prevention and control in special setting (e.g. operating room, dialysis, endoscopes, etc)
Hospital environmental infection prevention and control
Occupational health and vaccination for healthcare workers
Healthcare-associated infections (e.g. bloodstream infection, surgical site infection, Clostridium difficile-associated disease, other nosocomial infections)
Device-associated infections (e.g. ventilator-associated pneumonia, catheter-related bloodstream infection, prosthetic joint infections, etc.)
Implementation science in antimicrobial resistance, antimicrobial stewardship, and infection prevention and control
Behaviour change in antimicrobial stewardship and infection prevention and control
Diagnostics for antibiotic stewardship
Diagnostics for infection prevention and control
Patient participation in infection prevention and antimicrobial stewardship
Healthcare worker education
Innovative approaches and new technologies in infection prevention and control and antimicrobial stewardship
Artificial Intelligence in antimicrobial resistance, antimicrobial stewardship, and infection prevention and control
Eco-responsibility of infection prevention and control
Waste management
One Health approach to tackling antimicrobial resistance